Value Addition in the Efficacy of Conventional Antibiotics by Nisin against Salmonella

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Singh, Aman Preet ^a   Prabha, Vijay ^a   Rishi, Praveen ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; EDETIC ACID; NISIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL SALMONELLOSIS; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL OUTER MEMBRANE; BROTH DILUTION; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INTESTINE; LIVER; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; SALMONELLA ENTERICA; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SCANNING ELECTRON MICROSCOPY; SPLEEN;

AMPICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; CEFOTAXIME; CEFTRIAXONE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; EDETIC ACID; FEMALE; INTESTINES; LIVER; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; NISIN; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; SPLEEN; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84885168425     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076844     Document Type: Article

References (38)

1. Chalon MC, Acuña L, Morero RD, Minahk CJ, Bellomio A, (2012) Membrane-active bacteriocins to control Salmonella in foods: Are they the definite hurdle? Food Res Int 45: 735-744.
2. Cohen ML, Tauxe RV, (1986) Drug-resistant Salmonella in the United States: An epidemiologic perspective. Science 234: 964-969.
3. Mølbak K, (2005) Human health consequences of antimicrobial drug-resistant Salmonella and other foodborne pathogens. Clin Infect Dis 41: 1613-1620.
4. Joerger RD, (2003) Alternatives to antibiotics: bacteriocins, antimicrobial peptides and bacteriophages. Poult Sci 82: 640-647.
5. Birosova L, Mikulasova M, (2009) Development of triclosan and antibiotic resistance in Salmonella enterica serovar Typhimurium. J Med Microbiol 58: 436-441.
6. Li B, Yu JPJ, Brunzelle JS, Moll GN, Van der Donk WA, et al. (2006) Structure and mechanism of the lantibiotic cyclase involved in nisin biosynthesis. Science 311: 1464-1467.
7. Rishi P, Preet S, Bharrhan S, Verma I, (2011) In-vitro and in-vivo synergistic effects of cryptdin 2 and ampicillin against Salmonella. Antimicrob Agents Chemother 55: 4176-4182.
8. Singh AP, Preet S, Rishi P, (2011) Augmentation of antimicrobial activity of conventional antibiotics by cell free extract of L. plantarum. J Antibiot 64: 795-798.
9. Hancock REW, Chapple DS, (1999) Peptide antibiotics. Antimicrob Agents Chemother 43: 1317-1323.
10. Hancock REW, Scott MG, (2000) The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci U S A 97: 8856-8861.
11. Preet S, Verma I, Rishi P, (2010) Cryptdin-2: a novel therapeutic agent for experimental Salmonella Typhimurium infection. J Antimicrob Chemother 65: 991-994.
12. Jay JM (2000) Modern Food Microbiology, 6th ed. Aspen Publishers Inc. Gaithersburg, Maryland. 679.
13. Murdock CA, Cleveland J, Matthews KR, Chikindas ML, (2007) The synergistic effect of nisin and lactoferin on the inhibition of Listeria monocytogenes and Escherichia coli O157:H7. Lett Appl Microbiol 44: 255-261.
14. Cutter CN, Siragusa GR, (1995) Population reduction of Gram negative pathogens Following Treatments with Nisin and Chelators. J Food Prot 58: 977-983.
15. Stevens KA, Sheldon BW, Klapes NA, Klaenhammer TR, (1991) Nisin treatment for inactivation of Salmonella species and other Gram-negative bacteria. Appl Environ Microbiol 57: 3613-3615.
16. Carneiro de Melo AM, Cassar CA, Miles RJ, (1998) Trisodium phosphate increase sensitivity of Gram-negative bacteria to lysozyme and nisin. J Food Prot 61: 839-844.
17. Solomakos N, Govaris A, Koidis P, Botsoglou N, (2008) The antimicrobial effect of thyme essential oil, nisin and their combination against Escherichia coli O157:H7 in minced beef during refrigerated storage. Meat Sci 80: 159-166.
18. Govaris A, Solomakos N, Pexara A, Chatzopoulou PS, (2010) The antimicrobial effect of oregano essential oil, nisin and their combination against Salmonella enteritidis in minced sheep meat during refrigerated storage. Int J Food Microbiol 137: 175-180.
19. Boziaris IS, Adams MR, (1999) Effect of chelators and nisin produced in situ on inhibition and inactivation of Gram negatives. Int J Food Microbiol 53: 105-113.
20. Lin CH, Hou RF, Shyu CL, Shia WY, Lin CF, et al. (2012) In-vitro activity of mastoparan-AF alone and in combination with clinically used antibiotics against multiple-antibiotic-resistant Escherichia coli isolates from animals. Peptides 36: 114-120.
21. Rishi P, Preet S, Kaur P, (2011) Effect of L. plantarum cell-free extract and co-trimoxazole against Salmonella typhimurium: a possible adjunct therapy. Ann Clin Microbiol Antimicrob 10: 9.
22. Yenugu S, Narmadha G, (2010) The human male reproductive tract antimicrobial peptides of the HE2 family exhibit potent synergy with standard antibiotics. J Pept Sci 16: 337-341.
23. Clinical and Laboratory Standards Institute (2010) Performance Standards for Antimicrobial Susceptibility Testing: 20th Informational Supplement M100-S20. CLSI, Wayne, PA, USA.
24. Rybak JM, McGrath J, (1996) Combination antimicrobial therapy for bacterial infections, Guidelines for the Clinician. Drugs 52: 390-402.
25. Serra P, Brandimarte C, Martino P, Carlone S, Giunchi G, (1977) Synergistic treatment of enterococcal endocarditis: in vitro and in vivo studies. Arch Intern Med 137: 1562-1567.
26. Raetz CRH, Whitfield C, (2002) Lipopolysaccharide endotoxins. Annu Rev Biochem 71: 635-700.
27. Vaara M, (1992) Agents that increase the permeability of the outer membrane. Microbiol Rev 56: 395-411.
28. Paul D, Cotter R, Ross P, Hill C, (2013) Bacteriocins- a viable alternative to antibiotics? Nat Rev Microbiol 11: 95-105.
29. Freeman MF, Gurgui C, Helf MJ, Morinaka BI, Uria AR, et al. (2012) Metagenome mining reveals polytheonamides as posttranslationally modified ribosomal peptides. Science 338: 387-390.
30. Ji HF, Shen L, Zhang HY, (2005) β-Lactam antibiotics are multipotent agents to combat neurological diseases. Biochem and Biophy Res Commun 333: 661-663.
31. Spratt BG, (1975) Distinct penicillin binding proteins involved in the division, elongation, and shape of Escherichia coli K12. Proc Natl Acad Sci U S A 72: 2999-3003.
32. Kitano K, Tomasz A, (1979) Triggering of autolytic cell wall degradation in Escherichia coli by beta-lactam antibiotics. Antimicrob Agents Chemother 16: 838-848.
33. Ruhr E, Sahl HG, (1985) Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles. Antimicrob Agents Chemother 27: 841-845.
34. Gut IM, Blanke SR, van der Donk WA, (2011) Mechanism of inhibition of Bacillus anthracis spore outgrowth by the lantibiotic nisin. ACS Chem Biol 6: 744-752.
35. Medeiros AA, (1997) Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics. Clin Infect Dis 24(Suppl 1): S19-45.
36. Ulvatne H, Karoliussen S, Stiberg T, Rekdal O, Svendsen JS, (2001) Short antibacterial peptides and erythromycin act synergically against Escherichia coli. J Antimicrob Chemother 48: 203-208.
37. Kalita A, Verma I, Khuller GK, (2004) Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy. J Infect Dis 190: 1476-1480.
38. Chaudhary U, Aggarwal R, (2004) Extended spectrum β-lactamases (ESBL)- An emerging threat to clinical therapeutics. Indian J Med Microbiol 22: 75-80.